Review and Update on Clinical Psychedelic Research
Year
2011 - Los Angeles, CA
Speakers
Moderator: Ralph Metzner, President, Green Earth Foundation
Rick Doblin, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), Boston, MA
Amanda Feilding, Executive Director, Beckley Foundation, Oxford, U.K.
Charles Grob, Director, Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of Psychiatry and Pediatrics at the UCLA School of Medicine, Los Angeles, CA
Bob Wold, Founder and President, Clusterbusters
We are now in the midst of a psychedelic research renaissance, with clinical studies under way at top medical schools and research institutes worldwide. To date, the results have shown that psychedelic-assisted therapy is more effective than conventional treatments for easing anxiety in the dying, interrupting the hold of addictive drugs, alleviating post-traumatic stress disorder, and treating other conditions. The idea of psychedelics as powerful psychiatric medicines is now beginning to be re-accepted by the medical community. What does this mean? And what new directions will the future hold?